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Abstract Interrogation of the Human Genome data for
sequences related to the von Willebrand factor A-domain module
identified a previously unreported 4.1 kb full-length cDNA that is
predicted to encode a new member of the collagen superfamily of
extracellular matrix proteins, collagen XXI. The domain
organization of collagen XXI comprised an N-terminal signal
sequence, followed by single von Willebrand factor A-domain and
thrombospondin domains, and an interrupted collagen triple
helix. The organization of these motifs predict that collagen XXI
is a new member of the FACIT collagen sub-family. Expression
analysis indicated that COL21A1 mRNA is present in many
tissues including heart, stomach, kidney, skeletal muscle and
placenta, and radiation hybrid mapping localized the COL21A1
gene to 6p11-12. ß 2001 Published by Elsevier Science B.V.
on behalf of the Federation of European Biochemical Societies.
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1. Introduction
The extracellular matrix (ECM) of connective tissues is a
highly regulated tissue-speci¢c network of collagens, non-col-
lagenous proteins and glycoproteins, and proteoglycans.
Many of these ECM components are composed of di¡erent
combinations of characterized protein domains or modules
[1]. The completion of the ¢rst draft of the Human Genome
Project makes it feasible to identify new modular ECM pro-
teins by database homology searching using these conserved
modules as probes. It is anticipated that this strategy will help
reveal the full complement of modular ECM proteins and
proteoglycans that so far have eluded conventional biochem-
ical identi¢cation.
One module present in a number of proteins is the type-A
domain, ¢rst described in von Willebrand factor (reviewed in
[2]). ECM components that contain one or more von Wille-
brand factor A-domains (VA) include ¢bril-associated colla-
gen with interrupted triple helices (FACIT) collagens XII [3],
XIV [4], and XX [5], collagens VI [6,7] and VII [8], matrilins
1^4 (reviewed in [9]), cochlin [10], polydom [11] and nine
transmembrane K integrin chains. The VA domain is an in-
dependently folding protein module that attains a classic K/L
‘Rossman’ fold consisting of a parallel L sheet surrounded by
amphipathic K helices and a metal-ion-dependent adhesion
site (MIDAS) at the C-terminal end of the L sheet [12^14].
Although the role of VA domains has not been precisely de-
¢ned, they appear to play an important role in protein^pro-
tein interactions [15^20].
To further de¢ne the molecular and biochemical roles VA
domains play in ECM architecture and function, we searched
the Human Genome database for novel VA-domain-contain-
ing proteins. In this report we describe COL21A1, a new VA-
domain-containing collagen with a domain structure that pre-
dicts it is a member of the FACIT collagen sub-family ex-
pressed in various tissues including heart, stomach, placenta,
skeletal muscle, kidney and liver.
2. Materials and methods
2.1. COL21A1 mRNA analysis
A poly(A) human multiple tissue expression (MTE) blot contain-
ing 76 tissues and cell lines (Clontech) was hybridized to a [32P]dCTP
random primer-labelled human COL21A1 polymerase chain reaction
(PCR) product ampli¢ed from the COL21A1 cDNA clone obtained
from the German cDNA Consortium (GenBank accession number
NM_030820). The 642 bp probe was generated using COL21A1F1
(32475P-GCTCCTCAGTCATTTGGAGC-3P3266) and COL21A1R1
(38895P-TGGACATGCACATASTAAGTG-3P3870) primers designed
to anneal within the 3P untranslated region of the COL21A1 cDNA.
The numbering of nucleotides is from the start of the clone including
the 5P untranslated region (see Fig. 1A). The PCR was performed in a
50 Wl reaction volume with 100 ng of COL21A1 template cDNA, 1.5
mM MgCl2 and 2.5 units of Taq polymerase (Perkin Elmer) at 94‡C
for 5 min, followed by 36 cycles of 94‡C for 30 s, 58‡C for 30 s, 72‡C
for 30 s, and a ¢nal extension at 72‡C for 7 min. Following overnight
hybridization at 65‡C in ExpressHyb hybridization solution (Clon-
tech), the blot was washed four times in 1USSC/1% SDS (w/v) at
65‡C, then twice in 1USSC/0.5% SDS (w/v) at 55‡C, exposed to a
phosphor-screen for 2^4 days and scanned with a Storm phosphor-
imager (Molecular Dynamics). The blot was stripped and re-probed
with a ubiquitin cDNA to con¢rm that approximately equal amounts
of poly(A) RNA were loaded on each dot.
A Northern blot containing poly(A) RNA (2 Wg per lane) from 12
human tissues (Clontech) was probed with the [32P]dCTP random
primer-labelled human COL21A1 PCR product in ExpressHyb hy-
bridization solution. The blot was washed to a stringency of
0.1USSC/0.1% SDS (w/v) at 55‡C and exposed to a phosphor-screen
as described above. The blot was stripped and re-probed with a hu-
man L-actin control cDNA to demonstrate that each lane contained
approximately equal amounts of poly(A) RNA.
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2.2. Chromosomal mapping of the human COL21A1 gene
The chromosomal location of the COL21A1 gene was determined
by radiation hybrid mapping [21] using the Genebridge 4 radiation
hybrid panel. Primers and ampli¢cation conditions were the same as
those used to generate the PCR probe for MTE and Northern anal-
ysis. The results were submitted to the Sanger Centre (http://
www.sanger.ac.uk/software/rhserver) for scoring using 2-pt RHMAP
software [22].
3. Results and discussion
3.1. Identi¢cation of COL21A1 cDNA
To identify novel VA-domain ECM proteins, the non-re-
dundant database at the National Center of Biotechnology
Information (NCBI) (http://www.ncbi.nlm.nih.gov/blast/)
was interrogated with the N-terminal VA-domain protein se-
quence of human matrilin-1 using the blastp program (v2.0).
One of the highest scoring hits, with an E value of 4U10324,
was a cDNA sequence encoding a previously unreported col-
lagen-like gene (GenBank accession numbers for the protein
and nucleotide sequences are NP_110447 and NM_030820,
respectively). This cDNA clone, which had been isolated
and sequenced in full by the German cDNA consortium
(http://www.rzpd.de/), was predicted to contain an uninter-
rupted protein coding region based on identi¢cation of a com-
plete open reading frame and a poly(A) tail at the 3P end of
the clone. To test the accuracy of the reported NM_030820
nucleotide sequence, it was used to interrogate the Human
Genome database at NCBI. Multiple hits were scored within
a BAC (NT_007336) clone assigned to a working draft of
chromosome 6 by the Sanger Centre. Inspection of the aligned
NM_030820 cDNA and two Sanger Centre genomic clones
(RP4-708F5 and RP1-181C24) revealed a nucleotide discrep-
ancy (A to C change at nucleotide 587) between the cDNA
and the two genomic clones, which is predicted to alter the
amino acid sequence (Asp to Ala). Interrogation of the Hu-
man EST database revealed that in an EST sequence
(BG699698) that covered this region, a C nucleotide was
present at nucleotide 587, thus con¢rming the BAC sequences
and suggesting that the nucleotide di¡erence in the cDNA
clone is either a cloning artefact or a polymorphism. Further-
more, since the alignment of the cDNA and genomic DNA
provides information about the position and size of exons and
introns, we can predict that this gene is approximately 190 kb
in size and is composed of 30 exons.
Initial inspection of the predicted protein sequence revealed
that in contains two signi¢cant repeating Gly-X-Y motifs of
339 and 112 amino acids in the C-terminus (Figs. 1A and 2A),
identifying it as a new member of the collagen family of ECM
proteins. We followed the traditional naming system for col-
lagens and assigned it the next sequential number, XXI.
3.2. Features of COL21A1 DNA and predicted protein
sequence
The COL21A1 cDNA is 4141 bp in size, exclusive of the
poly(A) tail, with a predicted start methionine at nucleotides
203^205 and a TAG stop codon at nucleotides 3074/3076
(Fig. 1A). The deduced open reading frame is 2873 bp in
size with 202 bp of 5PUTR and 1066 bp of 3PUTR.
The COL21A1 open reading frame encodes a 957 amino
acid protein with a predicted molecular weight of 99 kDa.
A 22 amino acid signal sequence with a cleavage site between
Ala22 and Glu23 is predicted by SignalP signal sequence pre-
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diction software (http://genome.cbs.dtu.dk/services/signalp-
2.0) [23] (data not shown). The signal sequence is followed
by a VA domain of approximately 170 amino acids from
amino acids 35^194, which contains a putative MIDAS [13],
and adjacent to the VA domain is a thrombospondin (TN)
domain spanning amino acids 229^412. At the C-terminal end
of the molecule distal to amino acid 449 are two collagen
triple helical domains (COL1 and COL2) separated by short
non-collagenous interruption (NC2). At the C-terminus is an-
other short non-collagenous domain (NC1) (Fig. 2A). There
are putative N-linked glycosylation sites at Asn66 and Asn329
that ¢t the consensus sequence NxS/T and potential O-linked
sites at Ser439, Thr440, Thr486, Ser645, Thr651, Thr679, Ser826
and Ser904, as predicted by NetOGlyc v2.0 software (http://
genome.cbs.dtu.dk/services/netoglyc) [24] (Fig. 1A).
3.3. Similarity of collagen XXI to the FACIT collagen sub-
family members
The modular organization and amino acid sequence identity
strongly suggest that collagen XXI belongs to the FACIT sub-
family of collagens, which include as members collagens XII,
XIV, XVI, XIX (reviewed in [25]) and XX [5]. The key struc-
tural feature which de¢nes the FACIT collagens is a pair of
highly conserved Cys residues separated by four amino acids
at the NC1^COL1 boundary (Fig. 2A). A second sequence
feature common to all FACIT collagens in the presence of
two imperfections in the Gly-X-Y repeat structure within
the COL2 domain [26]. Collagen XXI contains both the con-
served Cys residues at Cys936 and Cys941, and the two imper-
fections at amino acids 882^885 and 902^906. Another nota-
ble similarity between collagen XXI and the other FACIT
collagens is the size of the NC1, COL1, NC2 and COL2
domains of collagen XXI, which are broadly similar to those
in the other FACIT collagens (Table 1).
The NC3 domain of collagen XXI is composed of single
copies of VA and TN domains. All FACIT collagens contain
a TN domain immediately N-terminal to the NC2 domain,
but only collagens XII, XIV and XX contain one or more VA
domains. The TN domain, which is predicted to attain an
anti-parallel L-sheet structure, is composed of nine L strands
and is believed to be involved in molecular recognition [27].
The TN repeat of collagen XXI has the most identity to those
present in collagens XII, XIV and XX and is less related to
the sub-group of FACIT collagens that include IX, XVI and
XIX (not shown). The other feature of collagen XXI is the
presence of a VA domain, which is only found in FACIT
collagens XII, XIV and the recently described collagen XX
(Fig. 2B). All amino acids within the MIDAS motif which
have been found to be critical for ion-binding, Asp40, Ser42,
Ser44 and Thr113, are conserved in collagen XXI, although
further studies are required to directly demonstrate a func-
tional MIDAS motif. In addition, the overall arrangement
of K helices and L sheets that form the important secondary
structure framework that is shared between all VA-like do-
mains is conserved in collagen XXI. Thus, we conclude that
collagen XXI is member of the FACIT collagen sub-family
and is most closely related to the VA-domain-containing FA-
CIT collagens XII, XIV and XX. The currently accepted clas-
si¢cation of collagens as members of the FACIT family has
been based on homology to the prototypical FACIT collagen
IX (reviewed in [25]). The original de¢ning functional feature
of the FACIT collagens, association with interstitial collagen
Fig. 1. Sequence and modular organization of collagen. A: Nucleotide and deduced amino acid sequence of COL21A1 cDNA. The predicted
signal sequence is in italic type, the stop codon is marked with an asterisk and a potential polyadenylation site in the 3P untranslated region is
underlined. Putative N- (Asn66 and Asn329) and O-linked (Ser439, Thr440, Thr486, Ser645, Thr651, Thr679, Ser826, Ser904) glycosylation sites are
underlined and C-terminal cysteine residues (Cys936 and Cys941), conserved in all FACIT collagens, are in bold type. B: Modular structure of
FACIT collagen XII (long form), XIV, XX and XXI chains showing positions of VA, ¢bronectin type III repeat (F3), TN (TSP) and inter-
rupted collagen triple helix domains (drawn using standard symbols [35]).
Table 1
Amino acid length of interrupted collagen triple helix domains in FACIT collagens
Collagen chain NC1 domain COL1 domain NC2 domain COL2 domain
FACIT collagens containing VA domains
Human K1(XII) 19 103 43 152
Chicken K1(XIV) 119/88a 106 43 152
Chicken K1(XX) 15 102 45 154
Human K1(XXI) 21 112 39 339
FACIT collagens lacking VA domains
Human K1(IX) 30 115 30 339
Human K2(IX) 25 115 30 339
Human K3(IX) 22 112 31 339
Human K1(XVI) 26 106 39 422
Human K1(XIX) 19 70 44 168
aCollagen XIV has an alternatively spliced NC1 domain [25].
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¢brils, has been demonstrated for collagens IX, XII and XIV,
but not for collagens XVI, XIX and XX [5] (reviewed in
[25,28]). Likewise, we have yet to demonstrate that collagen
XXI can interact with other collagen types, but based on its
homology with collagens XII and XIV, we suggest that this
interaction is likely to occur.
3.4. Expression of COL21A1 mRNA
To determine the pattern of COL21A1 mRNA expression,
a MTE blot containing poly(A) RNA from 76 human and
fetal tissues and cell lines was hybridized to a COL21A1-spe-
ci¢c PCR product (Fig. 3A). COL21A1 mRNA was present in
a variety of tissues, but expression was highest in adult and
fetal heart, placenta, stomach, jejunum, skeletal muscle, kid-
ney, lung, pancreas and lymph node. Interestingly, there was
an asymmetric distribution of COL21A1 mRNA within the
heart, with the right ventricle and atrium expressing higher
levels compared to the left ventricle and atrium. The apex
Fig. 2. Alignment of the interrupted collagen triple helix and VA-domains of collagen XXI with homologous domains in other FACIT colla-
gens. Sites where amino acids are identical in all sequences are marked with an asterisk, conserved substitutions are marked with a colon and
semi-conserved substitutions with a full-stop. Alignments were performed using CLUSTALW (http://www.ch.embnet.org/software/clustalw.html)
[36] with some changes performed visually. A: Alignment of C-terminal interrupted collagenous region containing NC1, COL1, NC2 and
COL2 domains from FACIT collagens XII, XIV, XX and XXI. Sequences are human K1(XII) (GenBank accession number Q99715, amino
acids 2870^3063) and K1(XXI) (759^957), and chicken K1(XIV) (CAA50064, 1592^1825) and K1(XX) (AAK58847, 1281^1472) chains. The
complete COL1 and C-terminal end of the COL2 domains are shown in upper case, and the NC1 and NC2 are in lower case. Conserved Cys
residues are in bold type and conserved imperfections in the NC1 domain are underlined. B: Alignment of VA domains from FACIT collagens
XII, XIV, XX and XXI. The sequences are human K1(XII) VA domain-1 (amino acids 138^300), -2 (438^599), -3 (1197^1357) and -4 (2321^
2483 and K1 (XXI) (35^194), and chicken K1(XIV) VA domain-2 (1040^1199) and K1(XX) (239^402). Conserved amino acids important for the
MIDAS [13] are indicated (#).
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and septum of the heart also expressed high mRNA levels.
Re-probing the blot with a ubiquitin cDNA con¢rmed that
approximately equal amounts of mRNA were present on each
dot. This pattern of COL21A1 mRNA expression closely cor-
responds to that of the three chains of collagen V, COL5A1,
COL5A2 and COL5A3 [29]. Since the MTE analysis does not
provide information about transcript size, we also probed a
Northern blot containing mRNA from some of the human
tissues that were positive for COL21A1 on the MTE blot
(Fig. 3B). COL21A1 mRNA was detected in heart, placenta,
jejunum, skeletal muscle, colon, kidney, liver, lung and absent
or present at low levels in brain, spleen, thymus and periph-
eral leukocytes, con¢rming the pattern of expression deter-
mined by MTE analysis. In most of these tissues, a 4.2 kb
transcript was present, which is in good agreement with the
size of the 4142 bp NM_030820 cDNA clone, con¢rming that
it represents the full-length sequence. Interestingly, in heart
and skeletal muscle, an additional 2.4 kb band was present
that probably represents a splicing variant of the COL21A1
gene. Densitometric estimation using the phospho-imager in-
dicated that in skeletal muscle, the two splicing variants were
present in approximately equal amounts, but in heart, the 2.4
kb variant was 30-fold more abundant than the 4.2 kb ver-
sion. When the Northern blot was re-probed with L-actin
cDNA, a 2.0 kb transcript was detected in all tissues, con¢rm-
ing that approximately equal amounts of RNA were present
in each lane.
In summary, analysis of the predicted amino acid sequence
and the domain structure indicates that collagen XXI belongs
to the FACIT sub-family of collagens and is the smallest
member of this group reported to date. The mRNA expres-
sion data demonstrated that collagen XXI is present in tissues
containing abundant ECM and in particular, in tissues ex-
pressing a muscle phenotype such as heart, skeletal muscle,
and smooth muscle including stomach and jejunum, and in
placenta, which has a large blood vessel network. These tissue
are also enriched for collagen I and at least two members of
the FACIT collagen family, collagens XII and XIV, have been
shown to co-localize with collagen I [30,31] although a direct
interaction has yet to be demonstrated [32]. This data raise the
exciting possibility that co-expression of collagen XXI with
collagen I in muscle and other tissues may by analogy with
some of the other FACIT collagens, playing a role in the
organization of interstitial collagen ¢brils.
3.5. Chromosomal assignment of human COL21A1 gene
COL21A1 gene location was determined by radiation hy-
brid mapping [21], using PCR analysis of the Genebridge 4
radiation hybrid panel. COL21A1 mapped to marker AF-
M205yc7 with a maximum LOD score of 9.6, which places
the gene on chromosome 6p11-12. While no characterized
connective tissue disorder maps to 6p11-12, the importance
of FACIT collagens in ECM structure and function has
been demonstrated by the characterization of mutations in
collagen IX (COL9A2 and COL9A3) in multiple epiphyseal
dysplasia [33,34]. The marker, AFM205yc7, is a CA-repeat
polymorphism with a maximum heterozygosity of 0.8298,
and will be useful in screening families for linkage between
COL21A1 and potential disease phenotypes.
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